# Docetaxel

NDC: 47335-323
Generic name: Docetaxel
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20201126

FDA application: NDA022534

## Active ingredients

- DOCETAXEL ANHYDROUS: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"47335-323"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=47335-323
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c85b2c62-3c33-4cbc-8b79-d5e17851a1b4